Cytologic assessment of thyroid nodules – Updates in 2023 Bethesda reporting system, diagnostic challenges and pitfalls
This review summarizes changes and updates in the most recently published 2023 Bethesda System for Thyroid Cytopathology (TBSRTC). Further, the review focuses on challenges and pitfalls encountered in cytologic assessment of thyroid fine needle aspiration (FNA) specimens, with an emphasis on atypia...
Main Authors: | Xiaobing Jin, Xin Jing |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Human Pathology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772736X2400015X |
Similar Items
-
Prospective study of bethesda categories III and IV thyroid nodules: Outcomes and predictive value of BRAFV600E mutation
by: Shiga Rappai Chirayath, et al.
Published: (2019-01-01) -
Malignancy Rate in Thyroid Nodules with Atypia or Follicular Lesion of Undetermined Significance
by: Hamdan Ahmed Pasha, et al.
Published: (2020-01-01) -
Presurgical screening of fine needle aspirates from thyroid nodules for BRAF mutations: A prospective single center experience
by: Ramamoorthy Hemalatha, et al.
Published: (2018-01-01) -
Atypia of Undetermined Significance in Thyroid Fine-Needle Aspiration Cytology: Pathological Evaluation and Risk Factors for Malignancy
by: Şafak Akın, et al.
Published: (2017-09-01) -
Risk of malignancy in thyroid nodules classified as Bethesda categories III, III - subcategories and IV: 2.5 years study
by: Abeer M Ilyas, et al.
Published: (2023-01-01)